HERON THERAPEUTICS, INC. /DE/ (HRTX) Gross margin 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) gross margin by fiscal year — reported gross profit divided by reported revenue.
73.3%FY2025 · since FY2016: 97.3% → 73.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 73.3% | +0.1 pp |
| FY2024 | 73.2% | +24.5 pp |
| FY2023 | 48.8% | -0.3 pp |
| FY2022 | 49.0% | +2.3 pp |
| FY2021 | 46.7% | -12.5 pp |
| FY2020 | 59.2% | +1.4 pp |
| FY2019 | 57.8% | -6.7 pp |
| FY2018 | 64.5% | -20.6 pp |
| FY2017 | 85.1% | -12.2 pp |
| FY2016 | 97.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice